Documents & Financials

Regulatory

June 4, 2024Information Circular
June 4, 2024Proxy – Class C
June 5, 2023Information Circular
June 5, 2023Proxy – Class C
May 26, 2022Annual Information Form
April 27, 2022Information Circular
April 27, 2022Proxy – Class C 
June 30, 2021 Information Circular
June 30, 2021Proxy – Class C
May 22, 2020Information Circular
May 22, 2020Proxy – Class C
May 22, 2020Notice of Meeting
November 8, 2021Annual Information Form
November 29, 2021Preliminary Short Form Base Shelf Prospectus

Financial Reporting

March 31, 2024Q1 2024 – Quarterly MD&A
March 31, 2024Q1 2024 – Quarterly Financial Statements
December 31, 2023Annual MD&A
December 31, 2023Annual Financial Statement
September 30, 2023Q3 2023 – Quarterly MD&A
September 30, 2023Q3 2023 – Quarterly Financial Statement
June 30, 2023Q2 2023 – Quarterly MD&A
June 30, 2023Q2 2023 – Quarterly Financial Statement
March 31, 2023Q1 2023 – Quarterly MD&A
March 31, 2023Q1 2023 – Quarterly Financial Statement
December 31, 2022Annual MD&A
December 31, 2022Annual Financial Statement
September 30, 2022Q3 2022 – Quarterly Financial Statement
September 30, 2022Q3 2022 – Quarterly MD&A
June 30, 2022Q2 2022 – Quarterly Financial Statement
June 30, 2022Q2 2022 – Quarterly MD&A
March 31, 2022Q1 2022 – Quarterly Financial Statement
March 31, 2022Q1 2022 – Quarterly MD&A
December 31, 2021Annual Financial Statement
December 31, 2021Annual MD&A
September 30, 2021Q3 2021 – Quarterly Financial Statement
September 30, 2021Q3 2021 – Quarterly MD&A
June 30, 2021Q2 2021 – Quarterly Financial Statement
June 30, 2021Q2 2021 – Quarterly MD&A
March 31, 2021Q1 2021 – Quarterly Financial Statement
March 31, 2021Q1 2021 – Quarterly MD&A
December 31, 2020Annual Financial Statement
December 31, 2020Annual MD&A
September 30, 2020Q3 2020 – Quarterly Financial Statement
September 30, 2020Q3 2020 – Quarterly MD&A
June 30, 2020Q2 2020 – Quarterly Financial Statement
June 30, 2020Q2 2020 – Quarterly MD&A
March 31, 2020Q1 2020 – Quarterly Financial Statement
March 31, 2020 Q1 2020 – Quarterly MD&A
December 31, 2019Annual Financial Statement
December 31, 2019Annual MD&A
September 30, 2019Q3 2019 – Quarterly Financial Statement
September 30, 2019Q3 2019 – Quarterly MD&A

For the year ended December 31, 2023, fees paid or payable to KPMG LLP and its network firms for the audit of the financial statements of the Pender Growth Fund were $126,260. Fees for other services were $71,578.